Loading...

Foreign pharma faces tough choices in Russia

Image

01-Dec-15 When in May-15 Prime Minister Dmitry Medvedev tasked the government with creating a program of pharmaceutical import substitution, foreign companies were worried. Today, 60% of the drugs approved by the Russian government are produced domestically. Under the new policy, this share should increase to 90% by 2018. [image: Getty Images]

Read More

Vietnam's hospital fees to rise steeply in 2016

Image

23-Nov-15 Vietnam's will increase public hospital fees in early 2016, instead of Dec-15, Nguyen Nam Lien, the Ministry of Health has said. With this fee increase, patients will pay two to four times more than when using healthcare services at state-owned hospitals. Currently 73% of the population is covered by health insurance, which means 25 mn people are self-paying. [image: Dantri]

Read More

Myanmar introduces drug tenders for public hospitals

Image

12-Nov-15 Myanmar's public hospitals are now permitted to procure pharmaceuticals through a tender system. In 2014, the volume of drugs available at public hospitals was 35 times higher than in 2011. The tender system is expected to reduce the surpluses and shortages that were common under the former rationing system. [image: Taipei Times]

Read More

Fair Trade Commission investigating Siemens Korea

Image

05-Nov-15 Korea's Fair Trade Commission has launched an investigation of Siemens Korea’s alleged unfair business practices in the field of medical equipment. According to the FTC, Siemens has refused to provide MRI and CT equipment software ownership and provided only the right to use the software.

Read More

China launches pilot scheme to ease drug approvals

Image

05-Nov-15 China has launched a three-year pilot scheme to loosen approvals for new drugs, the country's food and drug regulator said, as Beijing looks to help stimulate innovation in the country's pharmaceutical sector. The trial will allow research and development bodies to seek drug approvals, which are currently restricted to drug manufacturers. [image: ET Healthworld]

Read More